H. pylori-Associated Gastritis, Gastritis after H. pylori Eradication and H. pylori-Negative Gastritis: Algorithm of Diagnosis and Treatment (Literature Review and Resolution of the Expert Panel of the Russian Gastroenterological Association)

Aim: to provide the basic points of the Expert Panel of the Russian Gastroenterological Association with discussion of measures to improve diagnostics, treatment and management of chronic gastritis patients. Key points. In the Russian Federation in 2021 more than 30 million patients diagnosed with “Gastritis and duodenitis” were recorded (K29 in accordance with International Classification of Diseases-10). H. pylori incidence rate in the Russian population has reduced and presently is about 40 %. In chronic gastritis pattern H. pylori -associated gastritis has still dominated though gastritis percent after successful H. pylori eradication, reactive gastropathy (including reflux gastritis) and autoimmune gastritis, has increased. Endoscopic and histologic examinations serve as key diagnostic techniques that provide a means for assessing the ethiology of gastritis, topography and degree of atrophic changes, gastritis staging as per OLGA/OLGIM system that properly correlates with the risk of stomach cancer and determines endoscopic examination strategy. H. pylori eradication therapy of gastritis serves as an etiotropic treatment and makes it possible to prevent progression of atrophy and stomach cancer. Conventional triple therapy combined with bismuth tripotassium dicitrate allows for achieving optimal cure rates of H. pylori eradication. Addition of rebamipide to regimens of H. pylori eradication improves their efficiency. Rebamipide arrests symptoms of dyspepsia in the case of chronic gastritis and functional dyspepsia. The administration of rebamipide for chronic gastritis makes it possible to influence the syndrome of increased epithelial permeability and inflammation, which makes it advisable to study it as a means of preventing stomach cancer and the progression of atrophy in various types of chronic gastritis. Conclusion. Members of the Expert Panel has approved the algorithm of diagnosis and treatment of H. pylori -associated gastritis, gastritis after H. pylori eradication and H. pylori -negative gastritis at the diagnostic stage in the case of initial presentation and long-term follow-up when needed.

Authors

Institutions

Publication Details

Journal
Russian Journal of Gastroenterology Hepatology Coloproctology
Published
2024-08-20
DOI
https://doi.org/10.22416/1382-4376-2024-34-3-7-23
Citations
11
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
6.30
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

H. pylori-Associated Gastritis, Gastritis after H. pylori Eradication and H. pylori-Negative Gastritis: Algorithm of Diagnosis and Treatment (Literature Review and Resolution of the Expert Panel of the Russian Gastroenterological Association)

Т. Л. Лапина, Yu. A. Kucheryavyy, М. Ф. Осипенко, N. V. Korochanskaya et al.
11 citations
Russian Journal of Gastroenterology Hepatology Coloproctology
Helicobacter pylori-related gastroenterology studies
6.30
article

H. pylori-Associated Gastritis, Gastritis after H. pylori Eradication and H. pylori-Negative Gastritis: Algorithm of Diagnosis and Treatment (Literature Review and Resolution of the Expert Panel of the Russian Gastroenterological Association)

Т. Л. Лапина, Yu. A. Kucheryavyy, М. Ф. Осипенко, N. V. Korochanskaya, В. В. Цуканов, Н. Н. Дехнич, А. С. Трухманов, И. В. Маев, Игорь Геннадьевич Бакулин, Н. В. Бакулина, С. С. Пирогов, Д. Н. Андреев, И. Б. Хлынов, О. А. Сторонова, Z. M. Galeeva, В. Т. Ивашкин, В. И. Симаненков, С. А. Алексеенко, Sayar R. Abdulkhakov, М. А. Ливзан, Roman Kuvaev, А. S. Tertychnyy, Д.С. Бордин, О. П. Алексеева, Yu. P. Uspenskiy
article en
11 citations

Abstract

Aim: to provide the basic points of the Expert Panel of the Russian Gastroenterological Association with discussion of measures to improve diagnostics, treatment and management of chronic gastritis patients. Key points. In the Russian Federation in 2021 more than 30 million patients diagnosed with “Gastritis and duodenitis” were recorded (K29 in accordance with International Classification of Diseases-10). H. pylori incidence rate in the Russian population has reduced and presently is about 40 %. In chronic gastritis pattern H. pylori -associated gastritis has still dominated though gastritis percent after successful H. pylori eradication, reactive gastropathy (including reflux gastritis) and autoimmune gastritis, has increased. Endoscopic and histologic examinations serve as key diagnostic techniques that provide a means for assessing the ethiology of gastritis, topography and degree of atrophic changes, gastritis staging as per OLGA/OLGIM system that properly correlates with the risk of stomach cancer and determines endoscopic examination strategy. H. pylori eradication therapy of gastritis serves as an etiotropic treatment and makes it possible to prevent progression of atrophy and stomach cancer. Conventional triple therapy combined with bismuth tripotassium dicitrate allows for achieving optimal cure rates of H. pylori eradication. Addition of rebamipide to regimens of H. pylori eradication improves their efficiency. Rebamipide arrests symptoms of dyspepsia in the case of chronic gastritis and functional dyspepsia. The administration of rebamipide for chronic gastritis makes it possible to influence the syndrome of increased epithelial permeability and inflammation, which makes it advisable to study it as a means of preventing stomach cancer and the progression of atrophy in various types of chronic gastritis. Conclusion. Members of the Expert Panel has approved the algorithm of diagnosis and treatment of H. pylori -associated gastritis, gastritis after H. pylori eradication and H. pylori -negative gastritis at the diagnostic stage in the case of initial presentation and long-term follow-up when needed.

Russian Journal of Gastroenterology Hepatology ColoproctologyVol. 34(3)
Privolzhsky Research Medical University (RU), Novosibirsk State Medical University (RU), Kuban State Medical University (RU), Sechenov University (RU), Kazan State Medical University (RU), Omsk State Medical University (RU), First Pavlov State Medical University of St. Petersburg (RU), Research Medical Center (US), Pirogov Russian National Research Medical University (RU), Moscow Clinical Scientific Center (RU), Ural State Medical University (RU), Research Institute of Medical Problems of the North (RU), Tver State Medical University (RU), Russian Medical Academy of Continuous Professional Education (RU), Smolensk State Medical University (RU), Siberian Branch of the Russian Academy of Sciences (RU), Kazan State Medical Academy (RU), Far Eastern State Medical University (RU), North-Western State Medical University named after I.I. Mechnikov (RU), Saint Petersburg State Pediatric Medical University (RU)
Good health and well-being
Openalex Percentile: Top 3%
Helicobacter pylori-related gastroenterology studies
6.30
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.